The CDC Director, Dr. Rochelle Walnsky, this week mentioned that the deaths amongst the adults due to Covid-19 are “at this point entirely preventable.” However, this is confirmed that the Covid-19 vaccination is effective, by a new analysis.
On Thursday, the analysis done as per the data provided by the US Government was released. This analysis shows that in the month of May, a total 18, 000 deaths occurred, and out of which 150 people who were completely vaccinated died. Thus, this data reveals that only about 0.8 percent or an average of five deaths were reported every day out of more than 200 average everyday deaths.
At the beginning of this year, in January, the average number of deaths that occurred was above 3,400 per day. In Addition, fully vaccinated people accounted for fewer than 1,200 of more than 853,000 hospitalized with the Covid-19 infection.
As per the data of the CDC, it was reported that about 63 percent of the American citizens, eligible for the vaccine, received at least their first dose of vaccination. Although, it is very important to take the complete doses of vaccines like Moderna and Pfizer-BioNTech in order to gain protection against Coronavirus.
Dr. Paul Offit, a vaccine researcher at the Children’s Hospital of Philadelphia mentioned, “The second shot is critical. We know from the phase one studies that the second shot induces a level of virus-specific neutralizing antibodies that’s about tenfold greater than that after the first dose.”
One of the recent researches done by the Centers for Disease Control and Prevention claims, “The adults above the age of 65 — the population most at risk — found that seniors who received partial vaccination were 64 percent less likely to be hospitalized, but fully vaccinated seniors were 94 percent less likely to be admitted to a hospital for Covid-19. ”
Further, another study was performed by the experts and they stated, “The two doses of the Pfizer-BioNTech vaccine were 88 percent effective in preventing illness caused by the Delta variant that originated in India, but one dose was only 33 percent effective. The new Novavax vaccine is even better, as per the trial data, with 90.4 percent efficacy even against variants.
